We want this to emerge not from the capital
En el sur de Chile, Puerto Varas se prepara para convertirse en el primer polo biotecnológico del país fuera de Santiago, respaldado por 7.500 millones de pesos del Estado. La apuesta no es solo económica: es una pregunta sobre si la innovación puede florecer lejos del centro, y si el talento científico puede encontrar su lugar sin emigrar a la capital. Con un horizonte de ocho años y cien empresas como meta, la ciudad lacustre asume un desafío que, de prosperar, podría rediseñar cómo Chile distribuye su futuro.
- Chile lleva décadas concentrando su innovación en Santiago, dejando a las regiones en un rol de espectadoras del desarrollo científico y tecnológico.
- Corfo adjudicó 7,5 millones de dólares a Puerto Varas para construir un laboratorio especializado y un ecosistema de apoyo a startups biotecnológicas, rompiendo ese patrón por primera vez.
- El alcalde Tomás Gárate presentó el proyecto como una declaración explícita: que las empresas de vanguardia pueden —y deben— nacer fuera de la capital.
- La meta es acelerar cien compañías en ocho años, conectando a científicos locales con mentores, inversores y mercados nacionales e internacionales.
- El verdadero desafío está por venir: atraer y retener talento, construir redes de inversión y demostrar que las ventajas del sur —recursos naturales, costos menores, comunidad científica emergente— pueden competir con la densidad de Santiago.
Puerto Varas, enclavada en la región de los lagos del sur de Chile, está a punto de convertirse en algo que el país nunca ha tenido: un hub dedicado exclusivamente a startups de base científica. El respaldo llegó de Corfo, la agencia estatal de fomento productivo, con una adjudicación de 7,5 millones de dólares destinados a construir infraestructura especializada y un ecosistema capaz de incubar cien empresas biotecnológicas en ocho años.
El alcalde Tomás Gárate anunció el proyecto en el programa Esa es la Idea de Cooperativa, y fue cuidadoso en subrayar lo que está en juego más allá de lo local. Durante décadas, la innovación científica en Chile ha gravitado casi exclusivamente hacia Santiago. Este hub es una apuesta deliberada por interrumpir esa lógica: dar a los científicos y emprendedores del sur un lugar donde desarrollar ideas, probarlas y escalarlas hacia mercados nacionales e internacionales, sin necesidad de emigrar al centro.
Lo que distingue al proyecto no es solo el monto invertido, sino la intención geográfica. Puerto Varas ya cuenta con reconocimiento internacional por su gestión municipal, lo que pudo haber inclinado la decisión de Corfo. Pero la prueba real será la ejecución: un laboratorio y una infraestructura de apoyo son condiciones necesarias, no suficientes. El hub deberá atraer talento, construir redes de mentoría e inversión, y abrir caminos reales para que las empresas crezcan más allá del mercado local.
Si el modelo funciona, otras regiones lo observarán con atención. El sur tiene ventajas concretas —proximidad a recursos agrícolas y marinos, costos más bajos, una comunidad científica en expansión— pero la pregunta de fondo sigue abierta: ¿pueden esas ventajas, sumadas a inversión focalizada, competir con la densidad de capital y redes que ofrece la capital? La respuesta comenzará a escribirse cuando los emprendedores, científicos e inversores que este ecosistema necesita decidan, efectivamente, aparecer.
Puerto Varas, a city in Chile's southern lakes region, is about to become something the country has never built before: a dedicated hub for science-based startups, anchored by $7.5 million in government funding. The money comes from Corfo, Chile's economic development agency, and the bet is straightforward—that a specialized laboratory and support infrastructure can nurture a hundred biotech companies into existence over the next eight years.
Mayor Tomás Gárate announced the award on a recent episode of Cooperativa's program Esa es la Idea, framing it as more than just a local win. The real ambition, he explained, is to break a pattern that has calcified Chilean innovation for decades: the assumption that serious scientific work happens in Santiago, and everywhere else follows. By building this hub in Puerto Varas, the city is positioning itself as a counterweight to that gravity. The goal is explicitly biotechnology-focused, designed to give local scientists and entrepreneurs a place to develop ideas, test them, and eventually scale them for national and international markets.
What makes this significant is not just the money or the infrastructure. It is the deliberate choice to locate innovation outside the capital. Gárate emphasized this repeatedly—the desire to see breakthrough companies "emerge not from the capital," as he put it. This is a statement about how Chile distributes its intellectual resources and economic opportunity. For years, talent and investment have flowed toward Santiago. This project asks whether the pattern can be reversed, or at least interrupted, by creating genuine competitive advantage in the south.
The city itself has already earned international recognition for its governance and management, which may have helped it secure the Corfo backing. But the real test will come in execution. A specialized laboratory and a supportive ecosystem are necessary conditions for startup success, but they are not sufficient. The hub will need to attract and retain talented scientists, connect them with experienced mentors and investors, and create pathways for their companies to grow beyond the local market. The eight-year timeline suggests Corfo and the city are thinking in terms of a genuine economic transformation, not a pilot project.
What emerges from this is a model that could be replicated. If Puerto Varas succeeds in accelerating a hundred biotech startups—companies that develop solutions to real problems and find customers willing to pay for them—other regions will take notice. The southern macrozone has natural advantages: proximity to agricultural and marine resources, a growing scientific community, and lower costs than Santiago. The question is whether those advantages, combined with focused investment and institutional support, can actually compete with the network effects and capital density of the capital.
For now, the city is moving forward with construction of the specialized laboratory and the broader infrastructure needed to support the hub. The announcement signals confidence from both the public and private sectors that this is worth doing. What happens next will depend on whether the entrepreneurs, scientists, and investors who are supposed to populate this ecosystem actually show up—and whether the companies they build can survive and thrive in a market that has long assumed innovation flows from one direction.
Notable Quotes
We want to accelerate 100 startups from here in eight years, benefiting local scientists.— Mayor Tomás Gárate
We want this to emerge not from the capital, breaking with traditional centralism in investment.— Mayor Tomás Gárate
The Hearth Conversation Another angle on the story
Why does it matter that this hub is in Puerto Varas and not Santiago? Isn't a startup a startup wherever it's located?
Not really. In Chile, the networks, the capital, the experienced mentors—they're all concentrated in Santiago. A scientist with a good idea in Puerto Varas has to either move or work at a distance. This hub removes that friction. It says: stay here, build here, and we'll give you the tools.
But $7.5 million doesn't sound like that much money for a hundred companies over eight years. That's $75,000 per startup.
You're right to be skeptical. That's seed funding for the infrastructure and support system, not for the companies themselves. The real money has to come from investors and from the companies' own revenue. The Corfo money is about creating the conditions where those other funding sources will show up.
What's the risk here? What could go wrong?
The biggest risk is that the hub becomes a nice building with good intentions but no actual companies. You need entrepreneurs willing to relocate or stay, you need investors who believe in the region, and you need problems worth solving. If any of those pieces is missing, the whole thing stalls.
Why biotechnology specifically? Why not software or other tech?
Biotech is capital-intensive and requires specialized infrastructure—labs, equipment, regulatory expertise. Software can happen anywhere with a laptop. By choosing biotech, Puerto Varas is saying: we're going to build something that requires us, that can't just happen in someone's apartment in Santiago.
Is this a sign that Chile is finally decentralizing its economy?
It's a sign that someone is trying. Whether it actually works depends on whether the market follows. Government can build the building and provide the funding, but it can't force investors or entrepreneurs to show up. That's the real test.